Akèy › Kansè kolon › Pennsylvania › Pittsburgh
Etid klinik pou Kansè kolon nan Pittsburgh, PA
9 etid pou Kansè kolon ap chèche patisipan nan sit nan ak bò kote Pittsburgh (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.
Tèks ofisyèl etid la (Anglè)
Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →
Distance-Based Exercise to Preserve Function and Prevent Disability
Ap rekrite
- UPMC Hillman Cancer Center, Pittsburgh
A Clinical Study of Calderasib (MK-1084) With Targeted Therapy and Chemotherapy in People With Colorectal Cancer (MK-1084-012/KANDLELIT-012)
Ap rekriteFaz 3
- UPMC Hillman Cancer Center ( Site 2024), Pittsburgh
Study of Elironrasib and Daraxonrasib as Monotherapies and Combination Therapy in Participants With Advanced KRAS G12C Mutant Solid Tumors
Ap rekriteFaz 1/2
- Allegheny Health Network, Pittsburgh
A Study to Evaluate the Efficacy and Safety of Standard-of-Care Chemotherapy and Bevacizumab With or Without INCA33890 in the First-Line Treatment of Metastatic Microsatellite Stable Colorectal Cancer
Ap rekriteFaz 3
- Allegheny General Hospital Cancer Institute, Pittsburgh
- Hillman Cancer Center, Pittsburgh
A Phase II Platform Study to Evaluate Treatment With Cemiplimab Monotherapy or Cemiplimab Plus Fianlimab or Other Novel Combinations in Patients With Colorectal Cancer With Minimal Residual Disease Following Definitive Surgery and Chemotherapy (EMPIRE)
Ap rekriteFaz 2
- Allegheny General Hospital, Pittsburgh
- Magee-Womens Hospital of UPMC, Pittsburgh
Five or Ten Year Colonoscopy for 1-2 Non-Advanced Adenomatous Polyps
Ap rekrite
- UPMC-Presbyterian Hospital, Pittsburgh
Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease
Ap rekriteFaz 2/3
- Allegheny General Hospital, Pittsburgh
- UPMC-Presbyterian Hospital, Pittsburgh
- UPMC-Saint Margaret, Pittsburgh
- ak 18 plis
Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors
Ap rekriteFaz 1
- University of Pittsburg Medical Center (UPCM), Pittsburgh
Patient Preference for Subcutaneous vs. Intravenous Immune Therapy
Ap rekriteFaz 2
- UPMC Hillman Cancer Center, Pittsburgh
Etid Kansè kolon nan lòt vil
- Boston, MA22 etid
- New York City, NY22 etid
- Houston, TX20 etid
- Los Angeles, CA16 etid
- Nashville, TN16 etid
- St. Louis, MO15 etid
- Arlington, VA15 etid
- Chicago, IL14 etid
- San Antonio, TX14 etid
- Baldwin Park, CA14 etid
- Baltimore, MD13 etid
- Tampa, FL13 etid
Lòt etid nan Pittsburgh
- Kansè Poumon ki pa ti selil48 etid
- Kansè (tout kalite)41 etid
- Kansè nan tete39 etid
- Kansè kolorektal32 etid
- Kansè Metastatik31 etid
- Melanom31 etid
- Kansè ovè30 etid
- Kansè Endomèt23 etid
- Kansè pwostat23 etid
- Kansè poumon23 etid
- Karsinòm selil skuamèz tèt ak kou22 etid
- Akidan serebavaskilè22 etid
Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.